TXG 10x Genomics, Inc. | US88025U1097
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 5.874.263.040 | 2.738.418.025,77 | 2.082.645.507,8 | 1.479.247.239,64 |
| Enterprise Value | 5.415.803.904 | 2.329.522.025,77 | 1.693.040.507,8 | 1.133.724.239,64 |
| Trailing P/E | - | - | - | - |
| Forward P/E | 223,88 | - | - | - |
| Price to Sales | 9,2 | 4,29 | 3,24 | 3,1 |
| Price to Book | 7,33 | 3,36 | 2,62 | 1,88 |
| EV/Revenue | 8,48 | 3,65 | 2,63 | 2,38 |
| EV/EBITDA | -176,59 | 52,51 | 1.069,51 | - |